Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,257,574
-$6,100,663 QoQ
Shares Held
664,286
-56.2% QoQ
Ownership
0.403%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 263 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2026CallValue
$942,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. NVAX ranks #72 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in NVAX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $942,000 | 100,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $6,257,574 | 664,286 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,358,237 | 1,518,211 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $284,900 | 35,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $2,375,520 | 353,500 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $110,443 | 16,435 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $866,880 | 129,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $4,061,895 | 468,500 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $997,050 | 115,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $840,270 | 96,917 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,951,550 | 468,500 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,102,500 | 175,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,721,085 | 268,500 | Put | Defined | 2025-07-21 | |
| 2025-03-31 | $801,250 | 125,000 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $1,756,740 | 218,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $1,957,650 | 155,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $1,496,655 | 118,500 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $1,940,778 | 153,300 | Put | Defined | 2024-09-16 | |
| 2024-06-30 | $1,519,200 | 120,000 | Call | Defined | 2024-09-16 | |
| 2024-03-31 | $1,456,944 | 304,800 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $983,040 | 204,800 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $905,000 | 125,000 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $2,823,400 | 380,000 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $23,731 | 3,194 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,148,300 | 310,000 | Put | Defined | 2023-05-15 | |
| 2022-06-30 | $25,715 | 500 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $15,193,778 | 83,800 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,069,734 | 63,400 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $64,730,348 | 597,419 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||